Literature DB >> 20513318

Lessons learned during the development of HumaPen memoir, an insulin pen with a memory feature.

Stuart D Breslin1, Debra A Ignaut, Douglas E Boyd.   

Abstract

Insulin pens are developed to address specific needs of diabetes patients for their pens, such as ease of use, portability, and discreetness. Like many consumer-based products, the development of insulin pens can pose significant challenges to the development team in that they must balance substantial accuracy requirements with aesthetic desires. The HumaPen Memoir team learned valuable lessons throughout the development process that may be worth highlighting. A keen understanding of the unmet needs of the patient population and a skillfully planned product generation map are critical to successful device development. A development team must decide whether to use a Quality Functional Deployment or system engineering-based development plan and, additionally, recognize where proof of concept ends and product development begins to maintain a strict timeline for the project. A proficiency in understanding and managing technical risk is critical to ensure a timely and high-quality product launch to the marketplace. (c) 2010 Diabetes Technology Society.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20513318      PMCID: PMC2901029          DOI: 10.1177/193229681000400306

Source DB:  PubMed          Journal:  J Diabetes Sci Technol        ISSN: 1932-2968


  9 in total

1.  Quality of life, treatment satisfaction, and treatment preference associated with use of a pen device delivering a premixed 70/30 insulin aspart suspension (aspart protamine suspension/soluble aspart) versus alternative treatment strategies.

Authors:  Richard R Rubin; Mark Peyrot
Journal:  Diabetes Care       Date:  2004-10       Impact factor: 19.112

2.  Adherence to preventive medications: predictors and outcomes in the Diabetes Prevention Program.

Authors:  Elizabeth A Walker; Mark Molitch; M Kaye Kramer; Steven Kahn; Yong Ma; Sharon Edelstein; Kellie Smith; Mariana Kiefer Johnson; Abbas Kitabchi; Jill Crandall
Journal:  Diabetes Care       Date:  2006-09       Impact factor: 19.112

3.  Accuracy of pen injectors versus insulin syringes in children with type 1 diabetes.

Authors:  A N Lteif; W F Schwenk
Journal:  Diabetes Care       Date:  1999-01       Impact factor: 19.112

4.  Preference for insulin delivery systems among current insulin users and nonusers.

Authors:  Kent H Summers; Sheryl L Szeinbach; Sheila M Lenox
Journal:  Clin Ther       Date:  2004-09       Impact factor: 3.393

5.  Medication adherence and the associated health-economic impact among patients with type 2 diabetes mellitus converting to insulin pen therapy: an analysis of third-party managed care claims data.

Authors:  Won Chan Lee; Sanjeev Balu; David Cobden; Ashish V Joshi; Chris L Pashos
Journal:  Clin Ther       Date:  2006-10       Impact factor: 3.393

6.  Use of an insulin pen by homeless patients with diabetes mellitus.

Authors:  Terry Wilk; Pablo F Mora; Susan Chaney; Kathleen Shaw
Journal:  J Am Acad Nurse Pract       Date:  2002-08

7.  Functionality and acceptability of a new electronic insulin injection pen with a memory feature.

Authors:  Willem J R R Venekamp; Lisa Kerr; Sherie A Dowsett; Patricia A Johnson; Deborah Wimberley; Chris McKenzie; James Malone; Zvonko Milicevic
Journal:  Curr Med Res Opin       Date:  2006-02       Impact factor: 2.580

8.  Comparison of NovoPen 3 and syringes/vials in the acceptance of insulin therapy in NIDDM patients with secondary failure to oral hypoglycaemic agents.

Authors:  A Kadiri; A Chraibi; F Marouan; M R Ababou; N el Guermai; A Wadjinny; A Kerfati; M Douiri; J D Bensouda; J Belkhadir; Y Arvanitis
Journal:  Diabetes Res Clin Pract       Date:  1998-07       Impact factor: 5.602

9.  A multicenter, randomized, open-label, comparative, two-period crossover trial of preference, efficacy, and safety profiles of a prefilled, disposable pen and conventional vial/syringe for insulin injection in patients with type 1 or 2 diabetes mellitus.

Authors:  Mary Korytkowski; David Bell; Carol Jacobsen; Rudee Suwannasari
Journal:  Clin Ther       Date:  2003-11       Impact factor: 3.393

  9 in total
  3 in total

Review 1.  Half-Unit Insulin Pens: Disease Management in Patients With Diabetes Who Are Sensitive to Insulin.

Authors:  David C Klonoff; Irina Nayberg; Udo Stauder; Hamid Oualali; Catherine Domenger
Journal:  J Diabetes Sci Technol       Date:  2016-11-28

2.  Analysis: desirable attributes of insulin injection pens that drive patient preference and compliance.

Authors:  Jeffrey D Zahn
Journal:  J Diabetes Sci Technol       Date:  2011-09-01

Review 3.  Analysis of symposium articles on insulin pen devices and alternative insulin delivery methods.

Authors:  Devra K Dang; Jennifer Lee
Journal:  J Diabetes Sci Technol       Date:  2010-05-01
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.